FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 are groups having the formulae shown below, and R2 is a 3-methyltetrahydro-2H-pyran-4-yl group or a 4-methoxycyclohexyl group. Disclosed compounds are PDE9 inhibitors. Invention also relates to particular compounds and a pharmaceutical composition comprising a compound of formula (III), or a pharmaceutically acceptable salt thereof.
R1: or or
EFFECT: objects of the invention are agents for alleviating cognitive impairment in Alzheimer's disease and a method for alleviating said disorder.
13 cl, 1 dwg, 3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PIRAZOLOQINOLINE DERIVATIVE | 2012 |
|
RU2605096C2 |
SALT OF PYRAZOLOQUINOLINE DERIVATIVE AND CRYSTAL THEREOF | 2014 |
|
RU2655171C2 |
NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS | 2016 |
|
RU2722149C1 |
NEW IMIDAZO[4,5-c]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS | 2018 |
|
RU2773516C2 |
DERIVATIVES OF CYCLOHEXANE OR TETRAHYDROPYRANE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR HYDRATES, OR SOLVATES OF THESE COMPOUNDS, OR THEIR SALTS, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND FUNGICIDE AGENT | 1992 |
|
RU2084439C1 |
IMIDAZOPIRASOTHINES AS PDE1 INHIBITORS | 2016 |
|
RU2712219C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR CFTR MODULATION | 2016 |
|
RU2752567C2 |
N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
TRICYCLIC COMPOUNDS OF BENZOPYRAN AS ANTIARRHYTHMIC AGENTS | 2005 |
|
RU2380370C2 |
Authors
Dates
2018-05-24—Published
2014-04-03—Filed